Skip to main content
. 1999 Dec 21;96(26):14949–14954. doi: 10.1073/pnas.96.26.14949

Figure 6.

Figure 6

Suppression of malignant conversion and aneuploidy by exogenous TGF-β1. (A) TGF-β1 suppresses the frequency of calcium-resistant foci in TGF-β1−/− keratinocytes. The indicated doses of TGF-β1 were added to keratinocytes 3 days after infection with v-rasHa and maintained through the course of the experiment. Each histogram represents the average of five to seven dishes. *, Significantly different from untreated keratinocytes (P < 0.0001). (B) The development of aneuploidy in TGF-β1−/− v-rasHa keratinocytes is suppressed by treatment with TGF-β1. Histogram shows the percentage of total mitoses with specific chromosome numbers. Treatment with TGF-β1 (50 pg/ml) was begun 3 days after infection with v-rasHa and continued for 15 days. A total of 90 metaphases from 2 independent experiments were counted. (C) Dose response for inhibition of DNA synthesis by exogenous TGF-β1 in v-rasHa-transduced TGF-β1−/− keratinocytes. DNA synthesis was measured by the incorporation of [3H]thymidine (3H-TdR).